Related Experiment Video
Updated: Jun 28, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Changes in coagulation factor XIII activity during resuscitation for hemorrhagic shock
Yusuke Yamada1,2, Tomohiro Abe1,3, Rina Tanohata1
1Department of Emergency and Critical Care Medicine, University of Miyazaki, Japan.
Factor XIII (FXIII) activity remains low during hemorrhagic shock resuscitation. Plasma transfusions did not adequately maintain FXIII levels, highlighting a critical gap in managing coagulation during trauma care.
Area of Science:
- Trauma and Emergency Medicine
- Hematology
- Coagulation Science
Background:
- Hemorrhagic shock resuscitation involves complex physiological changes.
- The role of factor XIII (FXIII) activity during this period is not well understood.
- Plasma transfusions are a common intervention, but their impact on FXIII levels is unclear.
Purpose of the Study:
- To evaluate changes in factor XIII (FXIII) activity during resuscitation for hemorrhagic shock.
- To assess the impact of plasma transfusions on FXIII levels in these patients.
Main Methods:
- Single-center observational study of 23 adult patients with hemorrhagic shock.
- Blood samples collected at arrival (T1), hemostasis completion (T2), and day 2 (T3).
- Measured FXIII activity and proportion of patients with adequate FXIII levels (>70%).
Main Results:
- Median FXIII activity was 53% on arrival and did not significantly increase by day 2.
- The proportion of patients with adequate FXIII activity decreased throughout resuscitation (30% at T1, 34% at T2, 21% at T3).
- Plasma transfusion did not significantly improve FXIII activity or the proportion of patients with adequate levels.
Conclusions:
- Factor XIII (FXIII) activity is insufficient in the early stages of hemorrhagic shock.
- Current resuscitation strategies, including plasma transfusion, do not adequately restore or maintain FXIII levels.
- Further research is needed to optimize FXIII management in trauma patients.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Clot Retraction and Fibrinolysis
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

